PD-0298029

PD-0298029
(IUPAC) ime
etil 3,6a,11,14-tetrahidro-9-metoksi-2-propil-3,5-dimetil-(12H)-izohino[1,2-b]pirolo[3,2-f][1,3]benzoksazin-1-karboksilat
KliniÄki podaci
Identifikatori
ATC kod nije dodeljen
ChemSpider[1] 26233369
Hemijski podaci
Formula C27H32N2O4 
Mol. masa 448,553 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

PD-0298029 je lek koji deluje kao selektivni antagonist za muskarinski acetilholinski receptor M4. On je razvijen za leÄenje Parkinsonove bolesti, ali je zbog slabe biodostupnosti i brzog metabolizma njegova primena u životinjskim studijama ograniÄena. On se prvenstveno koristi u in vitro istraživanjima M4 i drugih muskarinskih receptora.[2][3][4]

Reference

  1. ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text miningâ€. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  2. ↑ Böhme TM, Augelli-Szafran CE, Hallak H, Pugsley T, Serpa K, Schwarz RD (July 2002). „Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptorsâ€. Journal of Medicinal Chemistry 45 (14): 3094–102. DOI:10.1021/jm011116o. PMID 12086495. 
  3. ↑ Boehme TM, Angelli-Szafran CE, Corinne E, Hallak H and Schwarz RD. Analogs of M4 selective synthetic muscarinic receptor antagonists: Synthesis, binding and pharmacokinetic properties. Medicinal Chemistry Research. 2002; 11(8):423–433.
  4. ↑ Progress in Medicinal Chemistry 43. (2005). Chapter 4, Muscarinic Receptor Subtype Pharmacology and Physiology, by Richard M Eglen. pp 128-129. ISBN 0-444-51572-0

Povezano

Vanjske veze